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Background
End stage renal disease (ESRD) patients suffer high cardiovascular mortality rates with fibrosis-induced arrhythmia recognized as a leading contributor. Since ESRD patients are contraindicated to standard gadolinium-based fibrosis imaging, non-contrast cardiac magnetic resonance imaging (CMR) techniques could improve diagnosis and empower evaluation of emerging anti-fibrotic therapies. With remodeling and increased extracellular water volume, a corresponding and measurable loss of magnetization transfer (MT) occurs. We previously demonstrated the ability to identify tissue that enhances with gadolinium based on differences between pairs of differentially MTweighted balanced steady state free precession (bSSFP) images 1,2 ( Figure 1A-C) . In this study, we seek to apply non-contrast MT-based tissue characterization in ESRD patients.
Methods
ESRD patients on routine hemodialysis and healthy controls (n = 9/group to date) were imaged on a 1.5T Siemens Aera scanner. Pairs of prospectively gated cine bSSFP images were obtained at flip angles of 50 and 45°from base to apex [TR/TE=35.64/1.36 ms, FOV=260 × 260 mm 2 , Matrix=256 × 256, Thickness=8 mm, phases set to fill the cardiac interval]. Maps of ΔS/S o were generated as ΔS/S o =(S 45 -S 5 )/S 5 *100 (%), where S i is the signal intensity per voxel at flip angle i. We analyzed cardiac structure and global function. A custom feature tracking algorithm measured circumferential and longitudinal strains. The distribution of ΔS/S o values across all controls was used to define a reference standard. To account for variations in heart size, this distribution was dynamically resized to simulate a cumulative distribution function of ΔS/S o matching the number of voxels per individual heart. Each subject's observed ΔS/S o distribution was compared to the appropriately-sized healthy standard using a one-sided Kolmogorov-Smirnov (KS) test.
Results
While septal wall thickness was heightened in ESRD patients (Table 1) , ejection fraction and peak circumferential and longitudinal strains were similar to controls. A sample ΔS/S o map in an ESRD patient ( Figure 1E ) demonstrates scattered enhancement compared to a healthy control ( Figure 1D ). Corresponding ΔS/S o distributions ( Figure 1F ) reveal a right skew in the ESRD patient, consistent with tissue remodeling. KS analysis revealed a trend toward greater rightward shift for ESRD patients (avg=13%, range: 3-48%) than controls (avg=4%: 0-12%, p = 0.12 vs. ESRD) when compared to the healthy standard. Four ESRD patients and only 1 control displayed ΔS/S o distributions that diverged from the standard distribution by more than 10%.
Conclusions
MT-weighted bSSFP imaging revealed a promising trend towards elevated ΔS/S o values in ESRD patients compared to controls, despite preserved contractile function. Analysis of ΔS/S o distributions may provide a rapid and endogenous mechanism for myocardial tissue characterization in ESRD patients. Ongoing participant recruitment will increase sample sizes and may reveal additional pathologies in ESRD patients. For each participant a simulated healthy standard distribution (black) was used to adjust for differences in heart size. A one-sided Komogorov-Smirnov test revealed a significant (p < 0.001) rightward shift in the ESRD patient (negative differential statistic = 14%) compared to no observable difference in the control subject (2%, N.S. vs healthy standard). 
